Cleared Traditional

K172471 - VENTANA CD30 (Ber-H2) RxDx Assay

K172471 is the FDA 510(k) clearance for VENTANA CD30 (Ber-H2) RxDx Assay by Ventana Medical Systems, Inc.. It is a Class 2 Medical Genetics device (product code DEH) cleared through the Traditional 510(k) pathway after a 266-day FDA review.

K172471 · Ventana Medical Systems, Inc. · Medical Genetics device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2018
Decision
266d
Days
Class 2
Risk

K172471 is an FDA 510(k) clearance for the VENTANA CD30 (Ber-H2) RxDx Assay. Classified as Lambda, Antigen, Antiserum, Control (product code DEH), Class II - Special Controls.

Submitted by Ventana Medical Systems, Inc. (Tucson, US). The FDA issued a Cleared decision on May 8, 2018 after a review of 266 days - an extended review cycle.

This device falls under the Medical Genetics FDA review panel, regulated under 21 CFR 866.5550 - the FDA medical genetics device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Medical Genetics review framework, consistent with the majority of Class II 510(k) submissions.

View all Ventana Medical Systems, Inc. devices

Submission Details

510(k) Number K172471 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 15, 2017
Decision Date May 08, 2018
Days to Decision 266 days
Submission Type Traditional
Review Panel Medical Genetics (MG)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
131d faster than avg
Panel avg: 397d · This submission: 266d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DEH Lambda, Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5550
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Medical Genetics devices follow this clearance model.

Regulatory Peers - DEH Lambda, Antigen, Antiserum, Control

All 43
Devices cleared under the same product code (DEH) and FDA review panel - the closest regulatory comparables to K172471.
FREELITE HUMAN LAMBDA FREE KIT
K140396 · The Binding Site Group , Ltd. · Apr 2014
FREELITE HUMAN KAPPA AND LAMBDA FREE KITS FOR USE ON THE OLYMPUS AU ANALYZER
K033811 · The Binding Site, Ltd. · Jan 2004
FREELITE HUMAN KAPPA AND LAMBDA FREE KITS FOR USE ON THE DAD BEHRING NEPHELOMETER II
K031016 · The Binding Site, Ltd. · Jul 2003
FREELITE HUMAN LAMBDA FREE KIT
K023131 · The Binding Site, Ltd. · Jan 2003
FREELITE LAMBDA FREE KIT
K010440 · The Binding Site, Ltd. · Apr 2001
FREELITE KAPPA FREE KIT
K010441 · The Binding Site, Ltd. · Apr 2001